Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Soyavit is an oral nutritional supplement and phytomedicine marketed by Juvenor Pharma, primarily in the form of a syrup. It is formulated with soy isoflavones, such as genistein and daidzein, which are plant-derived compounds that function as phytoestrogens. These isoflavones bind to estrogen receptors (ER-alpha and ER-beta), mimicking the effects of endogenous estrogen to a lesser degree. This action helps to alleviate vasomotor symptoms associated with menopause, such as hot flashes and night sweats, and may assist in maintaining bone mineral density in postmenopausal women. The product is often supplemented with essential vitamins and minerals to support overall metabolic health and nutritional balance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Soyavit.